New study on vaping shows that banning flavors could be detrimental to the goal of harm reduction

The argument that [vaping] appeals to youth and is directed solely at them is false

TORONTO (PRWEB)
November 18, 2019

180Smoke Vape Shop has interviewed Dr. Gopal Bhatnagar, a leading Canadian cardiac surgeon and head of cardiovascular surgery unit at the Trillium Health Centre on the recent vaping health crisis and his opinion on the political response across North America. He provides expert insight from a medical perspective on how vaping is used by smokers and clinicians as a cessation tool.

Dr. Bhatnagar stresses that the condemnation of vaping is a regressive step for society and calls out the media for not clearly identifying the difference between vaping eliquid and THC, which has influenced policy and regulations.

According to the latest CDC research, vitamin E acetate is a “chemical of concern” and was found in all of the patients who suffered from vaping related lung injuries. Vitamin E acetate might be used “as a thickening agent” in THC products.

A flavor ban would alienate 87% of vapers who do not prefer to vape tobacco or flavorless eliquids according to a recent study by 180Smoke. This user demographics study and associated infographic, revealed that the proposed Trump flavor ban would limit vapers to flavors that are preferred by only 13% of users. Experts believe that this could discourage others from considering vaping as an alternative nicotine delivery system.

The study also shows that younger people do not vape in larger numbers, and that the majority of those surveyed used to smoke and now only vape.

Founded by Boris Giller and Ashutosh Jha, 180Smoke is a vape shop and online store that offers e-cigarettes, vaporizers, and vape liquids. According to leading Canadian heart surgeon, Dr Gopal Bhatnagar, the vaping flavor ban proposed by Trump is incredibly dangerous.

Share article on social media or email:

BALTIMORE (PRWEB)
November 14, 2019

With Giving Tuesday on Dec. 3, 2019, the Veterans Affairs (VA) Maryland Health Care System reminds community members, businesses and organizations about the benefits of supporting local hospitalized veterans throughout Maryland. Created in 2012, Giving Tuesday is a global movement that inspires hundreds of millions of people to give, collaborate and celebrate generosity before the holidays, and enables participants to turn good intentions into action.

Each year, hundreds of Veterans spend the holidays at a VA Maryland Health Care System inpatient facility. Many of these hospitalized veterans may not have an opportunity to see family members and friends during the holiday season. On Giving Tuesday and throughout the year, community members, corporate donors and other organizations can support veteran inpatients by making a donation to the VA Maryland Health Care System’s Holiday Gift Program, which provides gift packages valued at $70 for each hospitalized veteran at the Baltimore, Loch Raven and Perry Point VA Medical Centers during the holiday season.

“The holidays can be a very lonely and challenging time of the year for many people, but this is even more evident for veterans who are hospitalized and far from their loved ones,” says Dr. Adam M. Robinson, Jr., director of the VA Maryland Health Care System. “GivingTuesday is a wonderful opportunity to support the needs of our hospitalized veterans this holiday season and to remind them that their service in the armed forces has not been forgotten.”

To make a donation, visit http://www.maryland.va.gov and click on “Volunteer or Donate” on the left side of the landing page, or call 410-642-2411, ext. 25409.    

# # #

The VA Maryland Health Care System (VAMHCS) is a dynamic and progressive health care organization that is dedicated to providing safe, quality and compassionate care to Maryland’s veterans. The Baltimore, Loch Raven and Perry Point VA Medical Centers, in addition to Cambridge, Eastern Baltimore County, Fort Meade, Glen Burnie and Pocomoke City VA Outpatient Clinics, all work together to form this integrated health care delivery system. Nationally recognized for its quality patient care and cutting-edge technology, the VAMHCS is proud of its reputation as a leader in veterans’ health care, research and education. The health care system is known for providing comprehensive services to veterans in Central Maryland and on Maryland’s Eastern Shore, including medical, surgical, rehabilitative, neurological, primary, mental health and long-term care on both an inpatient and outpatient basis. More than 53,000 veterans receive their care from the VAMHCS annually. All veterans are encouraged to apply for VA health care by calling 877-222-8387 or visiting http://www.va.gov.

Share article on social media or email:

HOUSTON (PRWEB)
November 18, 2019

MobilDrTech, Inc. is pleased to have been selected by RNK Products, Inc. (RNK), a pioneer in telemedicine stethoscopes and medical devices, to launch their new exam camera kit which breaks the barrier for value in a price sensitive market. Now there is a camera that providers can economically deploy across their programs.

Those in the market for telemedicine exam cameras, know that the market has, until now, priced out many providers due to the high price of available devices. Now there is a product that can be affordably used at virtually every telemedicine site. RNK has designed special components and software that can be used with off-the-shelf HD webcams to create a low cost, high quality exam cam with ENT (ear, nose, throat) capabilities.

MobilDrTech will offer parts kits for customers who want DIY components and a fully finished plug-and-play Exam Camera that is ready for clinic use right out of the box. The pricing is extremely attractive. MobilDrTech will offer a Logitech C920 Camera with Light Ring Kit for $178 and a kit that also includes the Otoscope Speculum for $277. Fully finished USB Exam Cams are available at only $249 for the base camera and $348 for the Exam Cam with the optional otoscope speculum. (See RExCam Kits Datasheet attached)

The RExCam Kit includes a software app (SDK is also available) that enables critical camera control, plus two custom designed hardware elements:

• A custom designed Light Ring attaches to the webcam so it can operate independently of ambient lighting. In addition to enhanced viewing of wounds and dermatology sites, the Light Ring enables clear, sharp viewing of the throat.
• A custom designed optics enhanced Speculum is inserted into the center of the Light Ring to enable viewing into the ear canal or nostril. The custom Speculum accepts off-the-shelf disposable speculum tips.

For over 10 years, MobilDrTech has been providing industry leading telemedicine equipment and helping customers find high quality, cost-effective solutions for their clinical services. We are privileged to be working with RNK and look forward to bringing the RExCam Kit and derivative products to market.

MobilDrTech will be selling the RExCam Kit from its’ online store at http://www.telemedicinesupply.com and to customers directly in U.S. and international markets. Kits and cameras are available immediately and will ship free via Fedex 2-day.

About MobilDrTech, Inc.: MobilDrTech is a full-service telemedicine systems and equipment supplier. Founded in 2009 and based in Houston, TX, MobilDrTech is a Value-Added Reseller (VAR) for leading telemedicine equipment manufacturers. https://mobildrtech.com

Share article on social media or email:

SEATTLE (PRWEB)
November 14, 2019

EMulate Therapeutics, Inc., a clinical-stage therapeutic device company developing non-invasive treatments for cancers and other serious diseases, announced it will have 5 poster presentations related to its medical devices for treating adult and pediatric brain cancers at the upcoming 24th Annual Society for Neuro-Oncology SNO Meeting in Phoenix, beginning on November 20 .

Two posters will be presented by Mike Butters, EMulate’s co-founder, at the affiliated SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS on Wednesday, November 20 at 5-7 pm. One poster describes the ability of the magnetic field of the device to penetrate the entire brain. The other poster provides early data to demonstrate that specific signals, referred to as cognates, can elicit differential behavioral responses in live animals.

Three poster presentations at the annual SNO meeting on Saturday, 23rd November, will provide updated data on the use of the Voyager ulRFE® system for treatment of patients with recurrent and newly diagnosed glioblastoma (GBM) and of the Hælo system to treat diffuse midline glioma (DMG), including diffuse intrinsic pontine glioma (DIPG).

The EMulate Voyager and Hælo systems appear to be safe for the treatment of adult and pediatric brain cancers; no serious device-related adverse events were reported. Additionally, the data from these feasibility studies suggest the EMulate Voyager and Hælo systems have clinical utility for the treatment of brain cancers and warrant further study in pivotal studies. Copies of the posters will be available at the EMulate exhibit table #312 at the SNO Conference.

Chris Rivera, EMulate Therapeutics President and Chief Executive Officer, made the announcement stating, “This year will mark our most active involvement in presenting clinical data and scientific technology regarding our proprietary Voyager and Hælo systems.”    

Rivera added “Our novel technology has the potential to transform the way we treat cancer. With these encouraging data in hand, we will continue to develop the EMulate Voyager system for the treatment of GBM and the Hælo system for the treatment of DMG/DIPG, with the aim to expand the underlying technology to additional indications in the future.”

Most recently, EMulate announced it had entered into an exclusive agreement for the distribution in India of the company’s proprietary systems for treatment of patients with selected brain cancer indications – both recurrent and newly diagnosed GBM and DMG/DPIG. The exclusive distributor is Sayre Therapeutics (Sayre), a Bangalore, India-based company that provides access to differentiated medical solutions to patients and clinicians in emerging markets by identifying high unmet needs across the healthcare continuum. The agreement with Sayre is EMulate’s second agreement with a highly-regarded international firm, the first being with Teijin Limited for the territory of Japan for the treatment of GBM.

EMulate will once again support the Annual SNO Conference at the Benefactor Sponsor Level.

About EMulate Therapeutics

Headquartered in Seattle, EMulate Therapeutics® is a clinical-stage therapeutic device company. EMulate has invented and patented a groundbreaking technology that utilizes precisely targeted ultra-low radio frequency energy (ulRFE®) to specifically regulate metabolic pathways on the molecular and genetic levels – without chemicals, radiation or drugs – delivered via a simple-to-use non-sterile, non-invasive, non-thermal, non-ionizing investigational device. The company’s goal is to transform disease treatment on a global scale with ulRFE, which can potentially be applied to a wide range of medical conditions as well as to veterinary medicine and non-medical applications. EMulate’s initial focus is on the treatment of patients with brain cancer, who are not well served by conventional standard of care therapies, which often result in poor outcomes and devastating side effects. Pre-clinical work is focused on exploring new applications in oncology. In addition, EMulate’s Voyager system for adults with GBM and its Hӕlo pediatric system are investigational medical devices in clinical development.

Media Relations Contact:

Dennis Kroft

dkroft@emulatetx.com

201-602-8354

Share article on social media or email:

SARASOTA, Fla. (PRWEB)
November 14, 2019

Colic Calm, the leading effective natural solution for infant digestive discomfort, has just announced the launch of their specially formulated five-strain probiotic with guaranteed live active cultures and 5 billion CFU per serving. Colic Calm and Colic Calm Plus have been a trusted companion for many moms with infants who struggle with colic, gas, and reflux. With the launch of the Colic Calm Probiotic, many parents may find continued relief and support of infant and child gut and digestive health.

Building a healthy microbiome is critical in the very early days to establish a healthy immune system, which not only prevents serious infections but is also thought to help prevent things like allergies, eczema, asthma, autoimmune conditions like type 1 diabetes, and even neurodevelopmental issues like autism and ADHD. The demand for safe, effective and living probiotics prompted Colic Calm to create a five-strain formulation with specific probiotics known to support digestive health. Colic Calm Probiotic comes as a one-time prep kit and includes a sachet of probiotics, a one-time use funnel, a bottle of MCT oil and a syringe.

“As leaders in infant gut health, we understand how important it is to have “good bacteria” to start your baby’s digestive system off right. We wanted to create a probiotic that had guaranteed live cultures, the most effective probiotic strains available and the highest CFU count per serving and is also free from sugar, gluten, wheat, soy, dairy and animal products,” said Keith Page, CEO of Colic Calm. “Colic Calm Probiotics are safe, gentle, and intended for everyday use.”

Since it was founded, Colic Calm has been dedicated to providing babies and parents with the highest-quality remedy for colic, gas and reflux. Now with the launch of the Colic Calm Probiotic, moms can trust they will receive the same quality and effectiveness that they’ve come to depend on with Colic Calm and Colic Calm Plus. Available nationally at Buy Buy Baby, Colic Calm Probiotic is also available online at Amazon.com, Walmart.com and ColicCalm.com with a suggested retail price of $19.95.

About Colic Calm

Colic Calm is the leader in effective natural solutions for infant digestive discomfort. From the start, Colic Calm has made it their mission to develop innovative, effective and natural wellness solutions. All products are made with the highest quality natural ingredients to empower families to be their best, and healthiest selves. Colic Calm, Colic Calm Plus and Colic Calm Probiotic provide effective relief without relying on synthetic-laden formulations.

For more information contact:

Anna Chase, Director of Marketing & Digital

US: +1 941 202 4802

E: anna@ketomi.com

Share article on social media or email: